prednisone,ponatinib
takeda,otsuka,incyte
['ponatinib', 'ph+ all', 'prednisone']
congress| #ash22| poster patrice nasnas, presented the 6-yr follow-up results on the frontline combination of hyper-cvad + ponatinib in pts with ph+ all, which demonstrated high efficacy (cmr,87%; 6-yr efs,65%; 6yr os,75%) and safety #allsm #medicalcongress 
A global education platform providing clinical updates on acute lymphoblastic leukemia. #leusm #allsm